Sofwave Announces FDA Clearance of New Lifting Indications
The new indications for the Sofwave system, now FDA cleared, include eyebrow lifts and lifting of lax tissue of the submental and neck areas.
The new indications for the Sofwave system, now FDA cleared, include eyebrow lifts and lifting of lax tissue of the submental and neck areas.
Incyte’s sNDA for ruxolitinib cream in children ages 2–11 now faces a new action date to allow additional data review.